Second-generation antipsychotics routinely breach the FDA’s level of concern of >7% body weight gain. This article examines the efficacy and safety of using off-label medications, such as metformin, to manage this side effect.

CME: Take the CME Post-Test for this episode  

Published On: 07/25/2022

Duration: 13 minutes, 19 seconds

Referenced Article: “Eating Disorders in Children and Adolescents ” The Carlat Child Psychiatry Report, July/August/September 2022

Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity